The relationship between pregnancy and the pituitary gland is a complex biological interaction driven by significant hormonal changes. During pregnancy, the pituitary gland naturally enlarges as the body prepares for lactation, primarily due to an increase in the number and size of lactotroph cells, which are responsible for producing prolactin. While this natural physiological expansion is normal, many women wonder if these high hormonal levels could trigger the development of a prolactinoma, a benign tumour of the pituitary gland. In the United Kingdom, clinical evidence suggests that while pregnancy does not typically cause a new tumour to form, it can have a notable impact on an existing prolactinoma. Understanding how the body’s hormonal environment interacts with the pituitary gland is essential for women planning a pregnancy or those already diagnosed with the condition.
What We’ll Discuss in This Article
- The physiological changes of the pituitary gland during a healthy pregnancy.
- Whether high oestrogen levels can trigger a new prolactinoma.
- The risks and management of existing prolactinomas during pregnancy.
- Clinical monitoring protocols for expectant mothers in the UK.
- The impact of breastfeeding on pituitary tumours.
- Statistics regarding tumour growth during the gestational period.
- Answers to common questions about fertility and pituitary health.
Physiological changes in the pituitary during pregnancy
During pregnancy, the pituitary gland undergoes a significant and predictable transformation to support the developing foetus and prepare for breastfeeding. Under the influence of rising oestrogen levels from the placenta, the lactotroph cells in the anterior pituitary increase in both size and number. This process, known as hyperplasia, can cause the entire gland to increase in volume by up to 130 percent by the time of delivery. This is a natural, non cancerous expansion that allows the body to meet the massive demand for prolactin needed for milk production.
Because the gland naturally grows during this time, it is important to distinguish this normal physiological growth from the development of a tumour. For most women, the pituitary gland returns to its original size within six months of giving birth. In the UK, if an MRI is performed during pregnancy for unrelated reasons, a radiologist must be careful not to mistake this natural enlargement for a pituitary adenoma. This natural growth is a sign of a healthy, functioning endocrine system responding to the unique demands of pregnancy.
Can pregnancy trigger the development of a new prolactinoma?
There is currently no strong clinical evidence to suggest that pregnancy increases the risk of developing a brand new prolactinoma. Prolactinomas are thought to arise from spontaneous genetic mutations within a single lactotroph cell, a process that is generally independent of external hormonal surges. While pregnancy creates an environment where prolactin levels are naturally very high, this does not typically cause a healthy cell to turn into a tumour. For the vast majority of women, the pituitary hyperplasia that occurs during pregnancy resolves completely after birth without any long term issues.
However, pregnancy can sometimes reveal a “silent” or undiagnosed prolactinoma that was already present. Because oestrogen stimulates the growth of lactotroph cells, it can also stimulate the growth of an existing, tiny tumour. A woman who previously had no symptoms might find that her prolactin levels stay high after she stops breastfeeding or that she develops headaches due to the tumour enlarging under the influence of pregnancy hormones. In these cases, it is not that pregnancy created the tumour, but rather that the hormonal changes made a pre existing, invisible problem become clinically apparent.
Managing an existing prolactinoma during pregnancy
For women already diagnosed with a prolactinoma, pregnancy requires careful specialist management. In the UK, the NHS guidance on pituitary issues and the Society for Endocrinology recommend that most women stop taking dopamine agonist medications (like cabergoline) as soon as a pregnancy is confirmed. This is because the risk of the medication affecting the baby is generally considered to be greater than the risk of the tumour growing during the nine months of pregnancy, especially for small microprolactinomas.
Clinical statistics indicate that the risk of a microprolactinoma (less than 10 millimetres) growing significantly during pregnancy is very low, affecting less than 3 percent of women. However, for those with a larger macroprolactinoma, the risk of clinically significant growth is higher, estimated at approximately 20 to 30 percent. For these patients, the British Endocrine Society advises monthly clinical reviews and visual field testing to ensure the tumour is not pressing on the optic nerves. If the tumour does grow significantly, medication may be restarted under close medical supervision to protect the mother’s vision.
Breastfeeding and its impact on the pituitary gland
One of the most common questions for women with a prolactinoma is whether it is safe to breastfeed. In the United Kingdom, breastfeeding is generally encouraged and is not thought to cause a prolactinoma to grow. While the act of breastfeeding keeps prolactin levels high, it is the placental oestrogen during pregnancy, rather than the act of nursing, that has the primary stimulating effect on the tumour cells. Once the placenta is delivered, the primary driver for tumour growth is removed.
Most women with a microprolactinoma can breastfeed for as long as they wish without any increased risk to their health. For those with larger tumours, doctors usually monitor for symptoms like new headaches or vision changes. In many cases, the high prolactin levels of breastfeeding act as a natural extension of the pregnancy period, and the tumour remains stable. Once breastfeeding concludes, the patient will typically have a repeat blood test and potentially a follow up MRI to assess the state of the tumour before resuming their usual medication.
Diagnostic challenges and MRI safety in pregnancy
Diagnosing or monitoring a pituitary tumour during pregnancy presents unique challenges. Blood tests for prolactin are not useful during this time because prolactin levels naturally rise to very high levels in every pregnant woman, sometimes exceeding 5,000 mU/L. Therefore, doctors cannot use blood work to tell if a tumour is growing. Instead, they must rely on the patient’s symptoms, particularly any changes in their peripheral vision or the onset of severe, persistent headaches.
If a tumour is suspected of growing rapidly and threatening the mother’s sight, an MRI scan may be necessary. In the UK, MRI is considered safe during the second and third trimesters, although it is usually performed without the “contrast” dye often used in other scans. This allows the medical team to get a clear view of the tumour’s size and its relationship to the optic nerves without exposing the baby to unnecessary chemicals. This careful, evidence based approach ensures the safety of both mother and child while managing the complexities of the endocrine condition.
Fertility and the path to pregnancy
For many women with a prolactinoma, the primary concern is actually achieving pregnancy in the first place. High prolactin levels normally suppress ovulation, making it difficult to conceive. However, with modern dopamine agonist treatments, most women are able to normalize their prolactin levels and restore their fertility quite quickly. In the UK, specialists often switch patients to a medication called bromocriptine when they are trying to conceive, as it has a longer track record of safety in early pregnancy compared to cabergoline.
Once a woman is on the correct dose of medication and her menstrual cycle has returned to normal, her chances of a successful pregnancy are the same as any other woman’s. The NICE clinical knowledge summaries suggest that with proper preconception planning and multidisciplinary care between an endocrinologist and an obstetrician, the vast majority of women with a prolactinoma have healthy, uncomplicated pregnancies. The focus is on achieving a stable hormonal state before conception to ensure the best possible start for the pregnancy.
Conclusion
Pregnancy does not increase the risk of developing a brand new prolactinoma, but the natural hormonal surges of oestrogen can stimulate the growth of an existing tumour. For women with small microprolactinomas, the risk of significant growth during pregnancy is very low, and most can safely stop medication until after delivery. Larger tumours require more careful monitoring to protect maternal vision, but breastfeeding remains safe for almost all patients. With specialized UK endocrine care, a prolactinoma should not prevent a woman from having a healthy pregnancy and birth. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can I take cabergoline while I am pregnant?
In the UK, it is usually recommended to stop cabergoline as soon as you find out you are pregnant, unless your specialist specifically tells you otherwise due to a very large tumour.
Will my prolactin levels ever return to normal after pregnancy?
Yes, for most women, prolactin levels return to their baseline within a few months of stopping breastfeeding.
Is it safe to have an MRI scan while I am pregnant?
Yes, MRI scans are generally considered safe during the second and third trimesters and are the preferred way to check for tumour growth if symptoms appear.
Why did my periods stop after my pregnancy ended?
If your periods do not return after you stop breastfeeding, it may be a sign that your prolactinoma is active again and requires a follow up with your endocrinologist.
Does having a prolactinoma mean I will have a high risk pregnancy?
Most pregnancies with a prolactinoma are considered low risk, but you will have extra monitoring of your vision and headaches as a precaution.
Can pregnancy “cure” a prolactinoma?
In rare cases, the changes in the pituitary during and after pregnancy can cause a tumour to shrink or even disappear, but this is not something that can be guaranteed.
Should I wait a certain amount of time after my diagnosis before getting pregnant?
Most specialists recommend waiting until your prolactin levels have been stable on medication for a few months before you start trying to conceive.
Authority Snapshot
This article provides a clinical overview of the relationship between pregnancy and prolactinomas to assist in patient education. The content has been authored by a specialized medical content team and reviewed by Dr. Rebecca Fernandez to ensure the highest standards of clinical accuracy. All information presented is strictly aligned with the latest NHS guidelines and UK endocrine society standards to provide reliable and safe information for patients.
